REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 14,000 individuals who have opted to be screened with Galleri®, a blood-based, multi-cancer early detection (MCED) test in routine clinical settings. The purpose of the study is to understand the real-world experience of Galleri® in clinical settings.
Study Type
OBSERVATIONAL
Enrollment
14,633
Vincere Cancer Center
Scottsdale, Arizona, United States
Providence
Burbank, California, United States
To describe signal detection and cancer detection within and across sites among participants who opt to receive Galleri® in a real world setting.
Time frame: Up to 12 Months
Galleri®: To assess the feasibility and acceptability of Galleri® from the perspective of participants and patient-reported outcomes (PROs) in a real-world setting.
Time frame: Up to 12 Months
HCRU: To assess healthcare resource utilization (HCRU) associated with cancer diagnostic workups for participants with signal detected Galleri® test results.
Time frame: Up to 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Providence, St. Jude
Fullerton, California, United States
Providence, Mission
Mission Viejo, California, United States
Providence, Orange County
Orange, California, United States
VA Miami Health Care System
Miami, Florida, United States
James A. Haley Veterans Hospital (VA Tampa)
Tampa, Florida, United States
Southeast Louisiana Veterans Health Care System (SLVHCS) (VA New Orleans)
New Orleans, Louisiana, United States
Boston VA Research Institute (VA Boston)
Boston, Massachusetts, United States
Providence
Portland, Oregon, United States
...and 6 more locations